852043-41-5

852043-41-5 structure
852043-41-5 structure

Name N-[(2S,3R,4E)-1,3-Dihydroxy-4-octadecen-2-yl](2H31)hexadecanamide
Synonyms Hexadecanamide-d, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-
N-[(2S,3R,4E)-1,3-Dihydroxy-4-octadecen-2-yl](H)hexadecanamide
Description C16-Ceramide-d31 is deuterium labeled C16-Ceramide.
Related Catalog
In Vitro Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[2].
References

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223.

Density 0.9±0.1 g/cm3
Boiling Point 675.4±55.0 °C at 760 mmHg
Molecular Formula C34H36D31NO3
Molecular Weight 569.092
Flash Point 362.3±31.5 °C
Exact Mass 568.706665
LogP 13.34
Vapour Pressure 0.0±4.7 mmHg at 25°C
Index of Refraction 1.480